Partner Byron McLain, who is the new president of the Langston Bar Association, was quoted in the Los Angeles Sentinel’s article, “Langston Bar Salutes Legal Luminaries, Awards $60,000 in Scholarships,” about the Langston Bar’s recent Gala on Saturday February 2, 2019.
The Langston Bar Association is the largest and oldest African-American organization of lawyers, judges and law students in the western United States. “Our mission is to empower leadership, advance the professional development of our members, and promote the administration of justice in the Black community and the community at large,” explained McLain.
McLain noted that he plans to raise $100,000 for scholarships under his tenure to help fund the tuition of law students.
The Langston Bar Association is the largest and oldest African-American organization of lawyers, judges and law students in the western United States. “Our mission is to empower leadership, advance the professional development of our members, and promote the administration of justice in the Black community and the community at large,” explained McLain.
McLain noted that he plans to raise $100,000 for scholarships under his tenure to help fund the tuition of law students.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”